News Daily News USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention Shelley Wood October 15, 2021
News Daily News CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD Yael L. Maxwell October 14, 2021
News Daily News Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT Michael O'Riordan October 04, 2021
News Daily News Heterozygous FH Diagnosed Late, Remains Undertreated Michael O'Riordan September 13, 2021
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Daily News Statins Positively Alter Coronary Plaque Composition Michael O'Riordan August 23, 2021
News Daily News Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA Yael L. Maxwell July 21, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News Less Cancer Among HF Patients Taking Statins, Registry Shows Michael O'Riordan June 23, 2021
News Daily News LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD Michael O'Riordan June 18, 2021
News Daily News ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients Caitlin E. Cox June 16, 2021
News Daily News AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards Michael O'Riordan June 02, 2021
News Conference News ACC 2021 High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE Michael O'Riordan May 15, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021